NNVC
NanoViricidesยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
NNVC Profile
Nanoviricides, Inc.
A company that developing therapeutics using nanomedicine technologies to treat viral infections
1 CONTROLS DRIVE, SHELTON, CONNECTICUT, 06484
--
NanoViricides, Inc., was incorporated in Nevada on April 1, 2005 and relocated to Delaware on May 30, 2023. The company is a clinical-stage company. The first drug is ready to enter the Phase II human clinical efficacy trial, and has successfully completed the Phase IA/IB human clinical safety and tolerability trials. They also have several additional drug candidates in various stages of preclinical development, including IND application stage and late-stage IND-supported non-clinical studies.
